CN104067126B - 用于检测人乳头瘤病毒并提供头颈部鳞状细胞癌预后的方法 - Google Patents

用于检测人乳头瘤病毒并提供头颈部鳞状细胞癌预后的方法 Download PDF

Info

Publication number
CN104067126B
CN104067126B CN201280067010.6A CN201280067010A CN104067126B CN 104067126 B CN104067126 B CN 104067126B CN 201280067010 A CN201280067010 A CN 201280067010A CN 104067126 B CN104067126 B CN 104067126B
Authority
CN
China
Prior art keywords
hnscc
hpv
prognosis
kit
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201280067010.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN104067126A (zh
Inventor
E·弗兰兹曼
L·佩雷拉
I·M·赖斯
R·C·邓肯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Miami
Original Assignee
University of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Miami filed Critical University of Miami
Publication of CN104067126A publication Critical patent/CN104067126A/zh
Application granted granted Critical
Publication of CN104067126B publication Critical patent/CN104067126B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • G01N2333/025Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70585CD44
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
CN201280067010.6A 2011-11-15 2012-11-15 用于检测人乳头瘤病毒并提供头颈部鳞状细胞癌预后的方法 Expired - Fee Related CN104067126B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161559974P 2011-11-15 2011-11-15
US61/559,974 2011-11-15
US201261654595P 2012-06-01 2012-06-01
US61/654,595 2012-06-01
PCT/US2012/065282 WO2013074793A1 (en) 2011-11-15 2012-11-15 Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

Publications (2)

Publication Number Publication Date
CN104067126A CN104067126A (zh) 2014-09-24
CN104067126B true CN104067126B (zh) 2017-04-12

Family

ID=48430146

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280067010.6A Expired - Fee Related CN104067126B (zh) 2011-11-15 2012-11-15 用于检测人乳头瘤病毒并提供头颈部鳞状细胞癌预后的方法

Country Status (13)

Country Link
US (3) US20140329230A1 (https=)
EP (1) EP2780714B1 (https=)
JP (1) JP6174035B2 (https=)
CN (1) CN104067126B (https=)
AU (3) AU2012340441A1 (https=)
BR (1) BR112014011563B1 (https=)
CA (1) CA2855971C (https=)
CO (1) CO6980621A2 (https=)
ES (1) ES2640532T3 (https=)
IL (1) IL232556A (https=)
MX (1) MX352642B (https=)
PE (1) PE20141565A1 (https=)
WO (1) WO2013074793A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012340441A1 (en) 2011-11-15 2014-05-29 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
WO2015017692A1 (en) * 2013-07-31 2015-02-05 University Of Miami Compositions and methods for identifying a risk of cancer in a subject
WO2015026827A2 (en) * 2013-08-19 2015-02-26 University Of Notre Dame Method and composition for detection of oncogenic hpv
WO2015179712A1 (en) 2014-05-22 2015-11-26 University Of Notre Dame Du Lac Integrated membrane sensor for rapid molecular detection
WO2016209703A1 (en) * 2015-06-22 2016-12-29 The Johns Hopkins University Head and neck squamous cell carcinoma assays
JP6655243B2 (ja) * 2015-09-01 2020-02-26 国立大学法人 鹿児島大学 口腔前癌病変の検出方法
CN107092854B (zh) * 2016-02-18 2020-05-22 财团法人金属工业研究发展中心 检测细胞受人类乳头瘤病毒(hpv)感染的装置及其检测方法
GB201808839D0 (en) 2018-05-30 2018-07-11 Cancer Research Tech Ltd Method of predicting survival rates for cancer patients
WO2020018954A1 (en) * 2018-07-20 2020-01-23 Predentome, Inc. Methods and systems for oral microbiome analysis
US20220137041A1 (en) * 2019-02-26 2022-05-05 University Of Miami Device for methods of detecting cancer
US20240188897A1 (en) * 2021-04-23 2024-06-13 The University Of Chicago Machine learning based histopathological recurrence prediction models for hpv+ head / neck squamous cell carcinoma
CN120359416A (zh) * 2022-10-17 2025-07-22 伟吉朗特生物科学公司 用于口腔癌风险的方法和组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403551A (en) 1993-09-16 1995-04-04 Roche Diagnostic Systems, Inc. Assaying device and container for in field analysis of a specimen and later shipment of the unadulterated specimen
US6235470B1 (en) 1993-11-12 2001-05-22 The Johns Hopkins University School Of Medicine Detection of neoplasia by analysis of saliva
US5990299A (en) * 1995-08-14 1999-11-23 Icn Pharmaceuticals, Inc. Control of CD44 gene expression for therapeutic use
US5976895A (en) 1996-03-11 1999-11-02 American Biomedica Corporation Device for the collection, testing and shipment of body fluid samples
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US6379620B1 (en) 1998-11-16 2002-04-30 Barry M. Tydings Assaying device and method for in field urinalysis
US6294349B1 (en) 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas
US7189397B2 (en) 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20040029114A1 (en) 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
ATE289685T1 (de) * 2003-08-25 2005-03-15 Mtm Lab Ag Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
JP4563186B2 (ja) 2004-02-16 2010-10-13 理研ビタミン株式会社 耐熱性が改善されたアントシアニン色素
WO2005095987A2 (en) * 2004-03-26 2005-10-13 University Of Miami Salivary soluble cd44: a molecular marker for head and neck cancer
WO2007129999A2 (en) 2004-07-14 2007-11-15 Biospectrum, Inc. Antiproliferative peptides and antibodies for their detection
US20090197285A1 (en) 2005-11-10 2009-08-06 University Of Kentucky Lung Cancer Diagnostic Assay
WO2007133725A1 (en) 2006-05-12 2007-11-22 University Of Miami Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
CN101230390A (zh) * 2007-12-07 2008-07-30 湖北大学 一种用于妇科恶性肿瘤早期筛选的基因芯片及其检测方法
EP2364371A4 (en) * 2008-11-24 2012-05-02 Univ Loma Linda BIOMARKER FOR DETECTING HEADS AND HALSTUMORS
AU2012340441A1 (en) 2011-11-15 2014-05-29 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

Also Published As

Publication number Publication date
BR112014011563A2 (pt) 2017-05-09
AU2020277155A1 (en) 2020-12-24
US20160305942A1 (en) 2016-10-20
IL232556A (en) 2017-12-31
EP2780714A1 (en) 2014-09-24
AU2018203361A1 (en) 2018-05-31
MX2014005887A (es) 2014-09-08
JP2014533372A (ja) 2014-12-11
EP2780714A4 (en) 2015-07-15
WO2013074793A1 (en) 2013-05-23
CN104067126A (zh) 2014-09-24
US20150219656A1 (en) 2015-08-06
PE20141565A1 (es) 2014-10-25
CA2855971C (en) 2022-01-04
US20140329230A1 (en) 2014-11-06
AU2012340441A1 (en) 2014-05-29
IL232556A0 (en) 2014-06-30
ES2640532T3 (es) 2017-11-03
US10180431B2 (en) 2019-01-15
EP2780714B1 (en) 2017-08-16
US10180430B2 (en) 2019-01-15
BR112014011563B1 (pt) 2022-05-24
MX352642B (es) 2017-12-01
JP6174035B2 (ja) 2017-08-02
AU2018203361B2 (en) 2020-08-27
CA2855971A1 (en) 2013-05-23
CO6980621A2 (es) 2014-06-27

Similar Documents

Publication Publication Date Title
CN104067126B (zh) 用于检测人乳头瘤病毒并提供头颈部鳞状细胞癌预后的方法
Aftab et al. Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer
Espinosa et al. Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer
JP6114035B2 (ja) 肺癌検出用唾液バイオマーカー
Dhanda et al. SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma
Kawai et al. Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia
CN111394456B (zh) 早期肺腺癌患者预后评估系统及其应用
JP6049739B2 (ja) 前立腺癌の分類のためのマーカー遺伝子
Mirghani et al. Diagnosis of HPV driven oropharyngeal cancers: comparing p16 based algorithms with the RNAscope HPV-test
AU2013277421A1 (en) Methods for head and neck cancer prognosis
CN116042832A (zh) 一种预测非小细胞肺癌免疫治疗获益程度及预后的生物标志物及应用
CN113462776B (zh) m6A修饰相关联合基因组在预测肾透明细胞癌患者免疫治疗疗效中的应用
Feng et al. Role of Epstein-Barr virus and human papillomavirus coinfection in cervical intraepithelial neoplasia in Chinese women living with HIV
Hu et al. Testing for viral DNA integration among HPV‐positive women to detect cervical precancer: An observational cohort study
Murphy et al. Tumor cell extrinsic synaptogyrin 3 expression as a diagnostic and prognostic biomarker in head and neck cancer
CN115637292B (zh) 预测肺腺癌患者小细胞转化风险的模型及其建立方法
Grincevičienė et al. Factors, associated with elevated concentration of soluble carbonic anhydrase IX in plasma of women with cervical dysplasia
Snietura et al. Human papillomavirus DNA in pharyngeal scrapes as a marker of HPV-related squamous cell cancer of the oropharynx
CN116042808A (zh) Gngt1在aub-m诊断中的应用
Xu et al. Three Autophagy-Related lncRNA are Prognostic Biomarkers for Patients with Head and Neck Squamous Cell Carcinoma
US20180163279A1 (en) Assay
Provencher Insulin-like Growth Factor-I and Risk of High-Grade Cervical Intraepithelial Neoplasia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170412